Double tribble: Two TRIB3 variants, Insulin, Akt, and eNOS

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 7, 2008, Pages 1216-1218

  Fleming, Ingrid ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DROSOPHILA PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANOSINE PHOSPHATE; INSULIN; INSULIN RECEPTOR; IONOMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRIB3 PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; GLYCOGEN SYNTHASE KINASE 3; NITRIC OXIDE; NOS3 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; REPRESSOR PROTEIN; TRIB3 PROTEIN, HUMAN;

CELL STIMULATION; EDITORIAL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; INSULIN SENSITIVITY; MOLECULAR MECHANICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASODILATATION; CARDIOVASCULAR DISEASE; ENZYMOLOGY; GENETICS; GENOTYPE; INSULIN RESISTANCE; METABOLISM; MUTATION; NOTE; PATHOPHYSIOLOGY; PHENOTYPE; PHOSPHORYLATION;

CARDIOVASCULAR DISEASES; CELL CYCLE PROTEINS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENOTYPE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INSULIN; INSULIN RESISTANCE; MUTATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; ONCOGENE PROTEIN V-AKT; PHENOTYPE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 46249094196     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.169250     Document Type: Editorial

References (31)

1. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007;28:463-491.
2. Du K, Herzig S, Kulkami RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 2003;300: 1574-1577.
3. Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J, Montminy M. PGC-1 promotes insulin resistance in liver through PPAR-a-dependent induction of TRB-3. Nat Med. 2004;10: 530-534.
4. He L, Simmen FA, Mehendale HM, Ronis MJJ, Badger TM. Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane: role of TRB3 in inhibition of Akt/protein kinase B activation. J Biol Chem. 2006;281:11126-11134.
5. Prudente S, Hribal ML, Flex E, Turchi F, Morini E, De Cosmo S, Bacci S, Tassi V, Cardellini M, Lauro R, Sesti G, Dallapiccola B, Trischitta V. The functional Q84R polymorphism of mammalian, tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes. 2005;54:2807-2811.
6. Andreozzi F, Formoso G, Prudente S, Hribal ML, Pandolfi A, Bellacchio E, Di Silvestre S, Trischitta V, Consoli A, Sesti G. TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. Arterioscler Thromb Vasc Biol. 2008;28: 1355-1360.
7. Fulton D, Gratton J-P, Mccabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein, kinase Akt. Nature. 1999;399: 597-601.
8. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601-605.
9. 2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res. 2001;88:e68-e75.
10. Michell BJ, Chen Z, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, Kemp BE. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein, kinase. J Biol Chem. 2001;276:17625-17628.
11. Lembo G, Iaccarino G, Rendina V, Volpe M, Trimarco B. Insulin blunts sympathetic vasoconstriction through the alpha 2- adrenergic pathway in. humans. Hypertension. 1994;24:429-438.
12. Hasdai D, Rizza RA, Holmes DR Jr, Richardson DM, Cohen P, Lerman A. Insulin, and insulin-like growth factor-I cause coronary vasorelaxation in vitro. Hypertension. 1998;32:228.
13. + channels on afferent arteriolar diameter in diabetes mellitus. JAm Soc. Nephrol. 2000;11:1199-1207.
14. McKay MK, Hester RL. Role of nitric oxide, adenosine, and ATP-sensitive potassium channels in insulin-induced vasodilation. Hypertension. 1996;28: 202-208.
15. Abbink-Zandbergen EJ, Vervoort G, Tack CJ, Lutterman JA, Schaper NC, Smits P. The role of adenosine in insulin-induced vasodilation. J Cardiovasc Pharmacol. 1999;34:374-380.
16. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin - direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.
17. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 1995;92: 2911-2918.
18. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron. AD. Insulinmediated skeletal muscle vasodilation is nitric oxide dependent. J Clin Invest. 1994;94:1172-1179.
19. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994;94:2511-2515.
20. Laight DW, Kaw AV, Carrier MJ, Anggard EE. Pharmacological modulation of endothelial function by insulin in the rat aorta. J Pharm Pharmacol. 1998;50:1117-1120.
21. Lembo G, Iaccarino G, Vecchione C, Barbato E, Morisco C, Monti F, Pattella L, Trimarco B. Insulin enhances endothelial α2-adrenergic vasorelaxation, by a pertussis toxin mechanism. Hypertension. 1997;30: 1128-1134.
22. Randriamboavonjy V, Schrader J, Busse R, Fleming I. Insulin, induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathway. J Exp Med. 2004;199:347-356.
23. 2+ level and contraction in the rat aorta. Circ Res. 1995;77: 673-678.
24. Trovati M, Massucco P, Mattiello L, Costamagna C, Aldieri E, Cavalot F, Anfossi G, Bosia A, Ghigo D. Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3 ' : 5 ' -cyclic monophosphate and adenosine 3 ' : 5 ' -cyclic monophosphate concentrations. Diabetologia. 1999;42:831-839.
25. Zeng G, Nystrom FH, Ravichandran. LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulinsignaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101:1539-1545.
26. 2+ but requires phosphorylation by Akt at Ser(1179). J Biol Chem. 2001;276:30392-30398.
27. Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D, Sbraccia P, Spagnoli LG, Sesti G, Lauro R. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation. modification of signaling proteins in human coronary endothelial cells. Circulation. 2002;106:466-472.
28. Wang XL, Zhang L, Youker K, Zhang MX, Wang J, LeMaire SA, Coselli JS, Shen YH. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes. 2006;55:2301-2310.
29. Fisslthaler B, Benzing T, Busse R, Fleming I. Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. Nitric Oxide. 2003;8:253-261.
30. Fisslthaler B, Loot AE, Mohamed A, Busse R, Fleming I. Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin. Circ Res. In press.
31. Bayer AL, Ferguson AG, Lucchesi PA, Samarel AM. PYK2 expression and phosphorylation in neonatal and adult cardiomyocytes. J Mol Cell Cardiol. 2001;33:1017-1030.